The impact of mast cells on cardiovascular diseases

European Journal of Pharmacology

Volumn 778, Issue , 2016, Pages 103-115

  Kritikou, Eva ^a   Kuiper, Johan ^a   Kovanen, Petri T ^b   Bot, Ilze ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b WIHURI RESEARCH INSTITUTE   (Finland)

Author keywords

Aneurysm; Arrhythmia; Atherosclerosis; Diabetes; Mast cells; Myocardial infarction; Obesity; Restenosis

Indexed keywords

ABDOMINAL AORTA ANEURYSM; ACUTE HEART INFARCTION; ARTICLE; ATHEROSCLEROSIS; ATRIAL FIBRILLATION; BRAIN ARTERY ANEURYSM; CARDIOVASCULAR DISEASE; CELL ACTIVATION; CELL INFILTRATION; DIABETIC NEPHROPATHY; DRUG ELUTING STENT; HEART VENTRICLE ARRHYTHMIA; HUMAN; MAST CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RESTENOSIS; ADVERSE EFFECTS; ANIMAL; CARDIOVASCULAR DISEASES; DIET; IMMUNOLOGY; PATHOLOGY;

ANIMALS; CARDIOVASCULAR DISEASES; DIET; HUMANS; MAST CELLS;

EID: 84929783424     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.04.050     Document Type: Article

References (195)

1. Eryd S. Adamsson, G. Östling, M. Rosvall, M. Persson, J.G. Smith, O. Melander, B. Hedblad, and G. Engström Carotid intima-media thickness is associated with incidence of hospitalized atrial fibrillation Atherosclerosis 233 2014 673 678
2. J.B. Atkinson, C.W. Harlan, G.C. Harlan, and R. Virmani The association of mast cells and atherosclerosis: a morphologic study of early atherosclerotic lesions in young people Hum. Pathol. 25 1994 154 159
3. P. Balakumar, A.P. Singh, S.S. Ganti, P. Krishan, S. Ramasamy, and M. Singh Resident cardiac mast cells: are they the major culprit in the pathogenesis of cardiac hypertrophy? Basic Clin. Pharmacol. Toxicol. 102 2008 5 9
4. M.A. Beaven Our perception of the mast cell from Paul Ehrlich to now Eur. J. Immunol. 39 2009 11 25
5. L. Bell, and J.A. Madri Effect of platelet factors on migration of cultured bovine aortic endothelial and smooth muscle cells Circ. Res. 65 1989 1057 1065
6. F. Borriello, F. Granata, G. Varricchi, A. Genovese, M. Triggiani, and G. Marone Immunopharmacological modulation of mast cells Curr. Opin. Pharmacol. 17 2014 45 57
7. I. Bot, S.C. de Jager, A. Zernecke, K.A. Lindstedt, T.J. van Berkel, C. Weber, and E.A. Biessen Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice Circulation 115 2007 2516 2525
8. I. Bot, S.C. de Jager, M. Bot, S.H. van Heiningen, P. de Groot, R.W. Veldhuizen, T.J. van Berkel, J.H. von der Thüsen, and E.A. Biessen The neuropeptide substance P mediates adventitial mast cell activation and induces intraplaque hemorrhage in advanced atherosclerosis Circ. Res. 106 2010 89 92
9. I. Bot, M. Bot, S.H. van Heiningen, P.J. van Santbrink, I.M. Lankhuizen, P. Hartman, S. Gruener, H. Hilpert, T.J. van Berkel, J. Fingerle, and E.A. Biessen Mast cell chymase inhibition reduces atherosclerotic plaque progression and improves plaque stability in ApoE-/- mice Cardiovasc. Res. 89 2011 244 252
10. I. Bot, and E.A. Biessen Mast cells in atherosclerosis Thromb. Haemost. 106 2011 820 826
11. I. Bot, G.P. Shi, and P.T. Kovanen Mast cells as effectors in atherosclerosis Arterioscler. Thromb. Vasc. Biol. 35 2015 265 271
12. M. Bot, S.C. de Jager, L. MacAleese, H.M. Lagraauw, T.J. van Berkel, P.H. Quax, J. Kuiper, R.M. Heeren, E.A. Biessen, and I. Bot Lysophosphatidic acid triggers mast cell-driven atherosclerotic plaque destabilization by increasing vascular inflammation J. Lipid Res. 54 2013 1265 1274
13. N. Boulet, D. Estève, A. Bouloumié, and J. Galitzky Cellular heterogeneity in superficial and deep subcutaneous adipose tissues in overweight patients J. Physiol. Biochem. 69 2013 575 583
14. G.A. Bray, and T. Bellanger Epidemiology, trends, and morbidities of obesity and the metabolic syndrome Endocrine 29 2006 109 117
15. H. Cao Adipocytokines in obesity and metabolic disease J. Endocrinol. 220 2014 T47 T59
16. S.J. Compton, J.A. Cairns, S.T. Holgate, and A.F. Walls Human mast cell tryptase stimulates the release of an IL-8-dependent neutrophil chemotactic activity from human umbilical vein endothelial cells (HUVEC) Clin. Exp. Immunol. 121 2000 31 36
17. P. Constantinides Mast cells and susceptibility to experimental atherosclerosis Science 117 1953 505 506
18. H.J. Cooke, P. Fox, L. Alferes, C.C. Fox, and S.A. Wolfe Presence of NK1 receptors on a mucosal-like mast cell line, RBL-2H3 cells Can. J. Physiol. Pharmacol. 76 1998 188 193
19. J.S. Dahlin, and J. Hallgren Mast cell progenitors: Origin, development and migration to tissues Mol. Immunol. 63 2015 9 17
20. S. Dai Ventricular histamine concentrations and arrhythmias during acute myocardial ischaemia in rats Agents Actions 21 1987 66 71
21. F.M. Davis, D.L. Rateri, and A. Daugherty Mechanisms of aortic aneurysm formation: translating preclinical studies into clinical therapies Heart 100 2014 1498 1505
22. N.M. De Jesus, L. Wang, A.W. Herren, J. Wang, F. Shenasa, D.M. Bers, M.L. Lindsey, and C.M. Ripplinger Atherosclerosis exacerbates arrhythmia following myocardial infarction: role of myocardial inflammation Heart Rhythm 12 2015 169 178
23. L.J. Dell'Italia, and A. Husain Dissecting the role of chymase in angiotensin II formation and heart and blood vessel diseases Curr. Opin. Cardiol. 17 2002 374 379
24. W.K. den Dekker, D. Tempel, I. Bot, E.A. Biessen, L.A. Joosten, M.G. Netea, J.W. van der Meer, C. Cheng, and H.J. Duckers Mast cells induce vascular smooth muscle cell apoptosis via a toll-like receptor 4 activation pathway Arterioscler. Thromb. Vasc. Biol. 32 2012 1960 1969
25. A. Dudeck, M. Leist, S. Rubant, A. Zimmermann, J. Dudeck, W.H. Boehncke, and M. Maurer Immature mast cells exhibit rolling and adhesion to endothelial cells and subsequent diapedesis triggered by E- and P-selectin, VCAM-1 and PECAM-1 Exp. Dermatol. 19 2010 424 434
26. M.R. de Vries, A. Wezel, A. Schepers, P.J. van Santbrink, T.M. Woodruff, H.W. Niessen, J.F. Hamming, J. Kuiper, I. Bot, P.H. Quax, J.F. Hamming, J. Kuiper, I. Bot, and P.H. Quax Complement factor C5a as mast cell activator mediates vascular remodelling in vein graft disease Cardiovasc. Res. 97 2013 311 320
27. A. Erdei, M. Andrásfalvy, H. Péterfy, G. Tóth, and I. Pecht Regulation of mast cell activation by complement-derived peptides Immunol. Lett. 92 2004 39 42
28. O. Erdogan, C. Gul, A. Altun, and G. Ozbay Increased immunoglobulin E response in acute coronary syndromes Angiology 54 2003 73 79
29. R.B. Ervin Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006 Natl. Health Stat. Rep. 13 2009 1 7
30. L.C. Faleiro, C.R. Machado, A. Gripp, R.A. Resende, and P.A. Rodrigues Cerebral vasospasm: presence of mast cells in human cerebral arteries after aneurysm rupture J. Neurosurg. 54 1981 733 735
31. Y.I. Fang, H. Namiki, E. Tsunoda, S. Shioda, M. Shibata, M. Nakatani, T. Katagiri, Y. Takeyama, H. Ohata, K. Honda, and K. Momose Marked increase in the histamine content of neointima after stent implantation of pig coronary artery and growth-promoting effects of histamine in cultured smooth muscle cells Life Sci. 77 2005 241 251
32. R. Feinstein, H. Kanety, M.Z. Papa, B. Lunenfeld, and A. Karasik Tumor necrosis factor-α suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates J. Biol. Chem. 268 1993 26055 26058
33. A.C. Foks, G.H. van Puijvelde, I. Bot, M.N. ter Borg, K.L. Habets, J.L. Johnson, H. Yagita, T.J. van Berkel, and J. Kuiper Interruption of the OX40-OX40 ligand pathway in LDL receptor-deficient mice causes regression of atherosclerosis J. Immunol. 191 2013 4573 4580
34. D.S. Friend, N. Ghildyal, K.F. Austen, M.F. Gurish, R. Matsumoto, and R.L. Stevens Mast cells that reside at different locations in the jejunum of mice infected with Trichinella spiralis exhibit sequential changes in their granule ultrastructure and chymase phenotype J. Cell. Biol. 135 1996 279 290
35. V. Fuster, L. Badimon, J.J. Badimon, and J.H. Chesebro The pathogenesis of coronary artery disease and the acute coronary syndromes N. Engl. J. Med. 326 1992 242 250
36. V. Fuster, B.B. Kelly, and R. Vedanthan Global cardiovascularhealth: urgent need for an intersectoral approach J. Am. Coll. Cardiol. 58 2011 1208 1210
37. S.J. Galli, J. Kalesnikoff, M.A. Grimbaldeston, A.M. Piliponsky, C.M. Williams, and M. Tsai Mast cells as "tunable" effector and immunoregulatory cells: recent advances Annu. Rev. Immunol. 23 2005 749 786
38. A.S. Go, and et al. Heart disease and stroke statistics - 2014 update: a report from the American Heart Association Circulation 129 2014 e28 e292
39. M.L. Gonzalez Suarez, D.B. Thomas, L. Barisoni, and A. Fornoni Diabetic nephropathy: Is it time yet for routine kidney biopsy? World J. Diabetes 4 2013 245 255
40. J.R. Gordon, and S.J. Galli Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses J. Exp. Med. 174 1991 103 107
41. T. Guo, W.Q. Chen, C. Zhang, Y.X. Zhao, and Y. Zhang Chymase activity is closely related with plaque vulnerability in a hamster model of atherosclerosis Atherosclerosis 207 2009 59 67
42. K.J. Haley, C.M. Lilly, J.H. Yang, Y. Feng, S.P. Kennedy, T.G. Turi, J.F. Thompson, G.H. Sukhova, P. Libby, and R.T. Lee Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis: using genomic technology to identify a potential novel pathway of vascular inflammation Circulation 102 2000 2185 2189
43. H.P. Hartung, and K.V. Toyka Substance P, the immune system and inflammation Int. Rev. Immunol. 4 1989 229 249
44. D. Hasan, N. Chalouhi, P. Jabbour, and T. Hashimoto Macrophage imbalance (M1 vs. M2) and upregulation of mast cells in wall of ruptured human cerebral aneurysms: preliminary results J. Neuroinflamm. 9 2012 222
45. G. He, J. Hu, T. Li, X. Ma, J. Meng, M. Jia, J. Lu, H. Ohtsu, Z. Chen, and X. Luo Arrhythmogenic effect of sympathetic histamine in mouse hearts subjected to acute ischemia Mol. Med. 18 2012 1 9
46. H.M. Heikkilä, S. Lätti, M.J. Leskinen, J.K. Hakala, P.T. Kovanen, and K.A. Lindstedt Activated mast cells induce endothelial cell apoptosis by a combined action of chymase and tumor necrosis factor-alpha Arterioscler. Thromb. Vasc. Biol. 28 2008 309 314
47. H.M. Heikkilä, J. Trosien, J. Metso, M. Jauhiainen, M.O. Pentikäinen, P.T. Kovanen, and K.A. Lindstedt Mast cells promote atherosclerosis by inducing both an atherogenic lipid profile and vascular inflammation J. Cell. Biochem. 109 2010 615 623
48. C.J. Helke, C.G. Charlton, and J.R. Keeler Bulbospinal substance P and sympathetic regulation of the cardiovascular system: a review Peptides 6 Suppl. 2 1985 S69 S74
49. K. Hiromura, M. Kurosawa, S. Yano, and T. Naruse Tubulointerstitial mast cell infiltration in glomerulonephritis Am. J. Kidney Dis. 32 1998 593 599
50. D.R. Holmes Jr., M. Savage, J.M. LaBlanche, L. Grip, P.W. Serruys, P. Fitzgerald, D. Fischman, S. Goldberg, J.A. Brinker, A.M. Zeiher, L.M. Shapiro, J. Willerson, B.R. Davis, J.J. Ferguson, J. Popma, S.B. King 3rd, A.M. Lincoff, J.E. Tcheng, R. Chan, J.R. Granett, and M. Poland Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial Circulation 106 2002 1243 1250
51. G.S. Hotamisligil, N.S. Shargill, and B.M. Spiegelman adipose expression of tumor necrosis factor-x: direct role in obesity-linked insulin resistance Science 259 1993 87 91
52. F.H. Hsieh, P. Sharma, A. Gibbons, T. Goggans, S.C. Erzurum, and S.J. Haque Human airway epithelial cell determinants of survival and functional phenotype for primary human mast cells Proc. Natl. Acad. Sci. USA 102 2005 14380 14385
53. Z.G. Huang, Q. Jin, M. Fan, X.L. Cong, S.F. Han, H. Gao, and Y. Shan Myocardial remodeling in diabetic cardiomyopathy associated with cardiac mast cell activation PLoS One 8 2013 e60827
54. M. Ihara, H. Urata, A. Kinoshita, J. Suzumiya, M. Sasaguri, M. Kikuchi, M. Ideishi, and K. Arakawa Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta Hypertension 33 1999 1399 1405
55. T. Inoue, K. Croce, T. Morooka, M. Sakuma, K. Node, and D.I. Simon Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis JACC: Cardiovasc. Interv. 4 2011 1057 1066
56. A.M. Irani, and L.B. Schwartz Human mast cell heterogeneity Allergy Proc. 15 1994 303 308
57. R. Ishibashi, T. Aoki, M. Nishimura, N. Hashimoto, and S. Miyamoto Contribution of mast cells to cerebral aneurysm formation Curr. Neurovasc. Res. 7 2010 113 124
58. M. Jeziorska, C. McCollum, and D.E. Woolley Mast cell distribution, activation, and phenotype in atherosclerotic lesions of human carotid arteries J. Pathol. 182 1997 115 122
59. D. Jin, S. Takai, M. Yamada, M. Sakaguchi, Y. Yao, and M. Miyazaki Possible roles of cardiac chymase after myocardial infarction in hamster hearts Jpn. J. Pharmacol. 86 2001 203 214
60. D. Jin, S. Takai, M. Yamada, M. Sakaguchi, K. Kamoshita, K. Ishida, Y. Sukenaga, and M. Miyazaki Impact of chymase inhibitor on cardiac function and survival after myocardial infarction Cardiovasc. Res. 60 2003 413 420
61. D. Jin, S. Takai, M. Sakaguchi, Y. Okamoto, M. Muramatsu, and M. Miyazaki An antiarrhythmic effect of a chymase inhibitor after myocardial infarction J. Pharmacol. Exp. Ther. 309 2004 490 497
62. D. Jin, H. Ueda, S. Takai, M. Muramatsu, K. Furubayashi, T. Ibaraki, K. Kishi, Y. Katsuoka, and M. Miyazaki Roles of chymase in stenosis occurring after polytetrafluoroethylene graft implantations Life Sci. 81 2007 1291 1300
63. J.L. Johnson, C.L. Jackson, G.D. Angelini, and S.J. George Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques Arterioscler. Thromb. Vasc. Biol. 18 1998 1707 1715
64. S.E. Jones, D.J. Kelly, A.J. Cox, Y. Zhang, R.M. Gow, and R.E. Gilbert Mast cell infiltration and chemokine expression in progressive renal disease Kidney Int. 64 2003 906 913
65. S.E. Jones, R.E. Gilbert, and D.J. Kelly Tranilast reduces mesenteric vascular collagen deposition and chymase-positive mast cells in experimental diabetes J. Diabetes Complicat. 18 2004 309 315
66. M. Juremalm, and G. Nilsson Chemokine receptor expression by mast cells Chem. Immunol. Allergy 87 2005 130 144
67. M. Kaartinen, A. Penttilä, and P.T. Kovanen Mast cells of two types differing in neutral protease composition in the human aortic intima. Demonstration of tryptase- and tryptase/chymase-containing mast cells in normal intimas, fatty streaks, and the shoulder region of atheromas Arterioscler. Thromb. 14 1994 966 972
68. M. Kaartinen, A. Penttila, and P.T. Kovanen Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture Circulation 90 1994 1669 1678
69. M. Kaartinen, A. Penttilä, and P.T. Kovanen Mast cells accompany microvessels in human coronary atheromas: implications for intimal neovascularization and hemorrhage Atherosclerosis 123 1996 123 131
70. H. Kanemitsu, S. Takai, H. Tsuneyoshi, T. Nishina, K. Yoshikawa, M. Miyazaki, T. Ikeda, and M. Komeda Chymase inhibition prevents cardiac fibrosis and dysfunction after myocardial infarction in rats Hypertens. Res. 29 2006 57 64
71. R. Kaur, L.A. Sloan, A.D. Blanchard, J.L. Smith, I. Churcher, G.J. Wayne, and S.B. Ludbrook A phenotypic screening approach in cord blood-derived mast cells to identify anti-inflammatory compounds J. Biomol. Screen. 18 2013 1223 1233
72. S. Kennedy, J. Wu, R.M. Wadsworth, C.E. Lawrence, and P. Maffia Mast cells and vascular diseases Pharmacol. Ther. 138 2013 53 65
73. M. Kinoshita, M. Okada, M. Hara, Y. Furukawa, and A. Matsumori Mast cell tryptase in mast cell granules enhances MCP-1 and interleukin-8 production in human endothelial cells Arterioscler. Thromb. Vasc. Biol. 25 2005 1858 1863
74. Y. Kitamura Heterogeneity of mast cells and phenotypic change between subpopulations Annu. Rev. Immunol. 7 1989 59 76
75. Y. Kitamura, K. Oboki, and A. Ito Development of mast cells Proc. Jpn. Acad. Ser. B. Phys. Biol. Sci. 83 2007 164 174
76. K. Koda, M. Salazar-Rodriguez, F. Corti, N.Y. Chan, R. Estephan, R.B. Silver, D. Mochly-Rosen, and R. Levi Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells Circulation 122 2010 771 781
77. J.O. Kokkonen, and P.T. Kovanen Low density lipoprotein degradation by rat mast cells. Demonstration of extracellular proteolysis caused by mast cell granules J. Biol. Chem. 260 1985 14756 14763
78. J.O. Kokkonen, and P.T. Kovanen Stimulation of mast cells leads to cholesterol accumulation in macrophages in vitro by a mast cell granule-mediated uptake of low density lipoprotein Proc. Natl. Acad. Sci. USA 84 1987 2287 2291
79. S. Kondo, S. Kagami, H. Kido, F. Strutz, G.A. Müller, and Y. Kuroda Role of mast cell tryptase in renal interstitial fibrosis J. Am. Soc. Nephrol. 12 2001 1668 1676
80. M.E. Korkmaz, A. Oto, Y. Saraçlar, E. Oram, A. Oram, S. Ugurlu, A. Karamehmetoglu, and E. Karaagaoglu Levels of IgE in the serum of patients with coronary arterial disease Int. J. Cardiol. 31 1991 199 204
81. N.G. Kounis, G. Hahalis, and T.C. Theoharides Coronary stents, hypersensitivity reactions, and the Kounis syndrome J. Interv. Cardiol. 20 2007 314 323
82. N.G. Kounis Coronary hypersensitivity disorder: the Kounis syndrome Clin. Ther. 35 2013 563 571
83. P.T. Kovanen The mast cell - a potential link between inflammation and cellular cholesterol deposition in atherogenesis Eur. Heart J. 14 Suppl. K 1993 105 117
84. P.T. Kovanen, M. Kaartinen, and T. Paavonen Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction Circulation 92 1995 1084 1088
85. P.T. Kovanen, M. Mänttäri, T. Palosuo, V. Manninen, and K. Aho Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M Arch. Intern. Med. 158 1998 1434 1439
86. S. Kraft, and J.P. Kinet New developments in FcepsilonRI regulation, function and inhibition Nat. Rev. Immunol. 7 2007 365 378
87. J.S. Kwon, Y.S. Kim, A.S. Cho, H.H. Cho, J.S. Kim, M.H. Hong, S.Y. Jeong, M.H. Jeong, J.G. Cho, J.C. Park, J.C. Kang, and Y. Ahn The novel role of mast cells in the microenvironment of acute myocardial infarction J. Mol. Cell. Cardiol. 50 2011 814 825
88. H.M. Lagraauw, M.M. Westra, M. Bot, A. Wezel, P.J. van Santbrink, G. Pasterkamp, E.A. Biessen, J. Kuiper, and I. Bot Vascular neuropeptide Y contributes to atherosclerotic plaque progression and perivascular mast cell activation Atherosclerosis 235 2014 196 203
89. P. Laine, M. Kaartinen, A. Penttilä, P. Panula, T. Paavonen, and P.T. Kovanen Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery Circulation 99 1999 361 369
90. P. Laine, A. Naukkarinen, L. Heikkila, A. Penttila, and P.T. Kovanen Adventitial mast cells connect with sensory nerve fibers in atherosclerotic coronary arteries Circulation 101 2000 1665 1669
91. H. Lappalainen, P. Laine, M.O. Pentikäinen, A. Sajantila, and P.T. Kovanen Mast cells in neovascularized human coronary plaques store and secrete basic fibroblast growth factor, a potent angiogenic mediator Arterioscler. Thromb. Vasc. Biol. 24 2004 1880 1885
92. J. Lappalainen, K.A. Lindstedt, R. Oksjoki, and P.T. Kovanen OxLDL-IgG immune complexes induce expression and secretion of proatherogenic cytokines by cultured human mast cells Atherosclerosis 214 2011 357 363
93. M. Lee, L.K. Lindstedt, and P.T. Kovanen Mast cell-mediated inhibition of reverse cholesterol transport Arterioscler. Thromb. 12 1992 1329 1335
94. M. Lee, L. Calabresi, G. Chiesa, G. Franceschini, and P.T. Kovanen Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux Arterioscler. Thromb. Vasc. Biol. 22 2002 1475 1481
95. M. Lee, C.P. Sommerhoff, A. von Eckardstein, F. Zettl, H. Fritz, and P.T. Kovanen Mast cell tryptase degrades HDL and blocks its function as an acceptor of cellular cholesterol Arterioscler. Thromb. Vasc. Biol. 22 2002 2086 2091
96. M. Lee-Rueckert, A. von Eckardstein, and P.T. Kovanen The neutral protease chymase degrades apolipoprotein E from high-density lipoproteins Clin. Chem. Lab. Med. 46 2008 421 423
97. M. Lee-Rueckert, R. Silvennoinen, N. Rotllan, I. Judström, F. Blanco-Vaca, J. Metso, M. Jauhiainen, P.T. Kovanen, and J.C. Escola-Gil Mast cell activation in vivo impairs the macrophage reverse cholesterol transport pathway in the mouse Arterioscler. Thromb. Vasc. Biol. 31 2011 520 527
98. A. Lerman, D.R. Holmes Jr., M.R. Bell, K.N. Garratt, R.A. Nishimura, and J.C. Burnett Jr. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans Circulation 92 1995 2426 2431
99. M.J. Leskinen, K.A. Lindstedt, Y. Wang, and P.T. Kovanen Mast cell chymase induces smooth muscle cell apoptosis by a mechanism involving fibronectin degradation and disruption of focal adhesions Arterioscler. Thromb. Vasc. Biol. 23 2003 238 243
100. M.J. Leskinen, H.M. Heikkilä, M.Y. Speer, J.K. Hakala, M. Laine, P.T. Kovanen, and K.A. Lindstedt Mast cell chymase induces smooth muscle cell apoptosis by disrupting NF-kappaB-mediated survival signaling Exp. Cell Res. 312 2006 1289 1298
101. S.P. Levick, G.C. Meléndez, E. Plante, J.L. McLarty, G.L. Brower, and J.S. Janicki Cardiac mast cells: the centrepiece in adverse myocardial remodelling Cardiovasc. Res. 89 2011 12 19
102. Y. Li, Y. Song, J. Mohler, and P. Delafontaine ANG II induces apoptosis of human vascular smooth muscle via extrinsic pathway involving inhibition of Akt phosphorylation and increased FasL expression Am. J. Physiol. Heart Circ. Physiol. 2699 2006 2116 2123
103. W.W. Li, T.Z. Guo, D.Y. Liang, Y. Sun, W.S. Kingery, and J.D. Clark Substance P signaling controls mast cell activation, derganulation, and nociceptive sensitization in a rat fracture model of complex regional pain syndrome Anesthesiology 116 2012 882 895
104. C.H. Liao, H. Akazawa, M. Tamagawa, K. Ito, N. Yasuda, Y. Kudo, R. Yamamoto, Y. Ozasa, M. Fujimoto, P. Wang, H. Nakauchi, H. Nakaya, and I. Komuro Cardiac mast cells cause atrial fibrillation through PDGF-A-mediated fibrosis in pressure-overloaded mouse hearts J. Clin. Investig. 120 2010 242 253
105. P. Libby, P.M. Ridker, and G.K. Hansson Progress and challenges in translating the biology of atherosclerosis Nature 473 2011 317 325
106. J. Liu, A. Divoux, J. Sun, J. Zhang, K. Clément, J.N. Glickman, G.K. Sukhova, P.J. Wolters, J. Du, C.Z. Gorgun, A. Doria, P. Libby, R.S. Blumberg, B.B. Kahn, G.S. Hotamisligil, and G.P. Shi Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice Nat. Med. 15 2009 940 945
107. M.F. Lopes-Virella, and G. Virella Pathogenic role of modified LDL antibodies and immune complexes in atherosclerosis J. Atheroscler. Thromb. 20 2013 743 754
108. L.F. Lu, E.F. Lind, D.C. Gondek, K.A. Bennett, M.W. Gleeson, K. Pino-Lagos, Z.A. Scott, A.J. Coyle, J.L. Reed, J. Van Snick, T.B. Strom, X.X. Zheng, and R.J. Noelle Mast cells are essential intermediaries in regulatory T-cell tolerance Nature 442 2006 997 1002
109. H. Ma, and P.T. Kovanen Inhibition of mast cell-dependent conversion of cultured macrophages into foam cells with antiallergic drugs Arterioscler. Thromb. Vasc. Biol. 20 2000 e134 e142
110. K. Maaninka, J. Lappalainen, and P.T. Kovanen Human mast cells arise from a common circulating progenitor J. Allergy Clin. Immunol. 132 2013 463 469
111. P.F. Mannaioni, M.G. Di Bello, S. Raspanti, V. Romano, T. Bani Sacchi, P. Cappugi, and E. Masini Storage and release of histamine in human platelets Inflamm. Res. 44 Suppl. 1 1995 S16 S17
112. A. Matsumori, Y. Furukawa, T. Hashimoto, A. Yoshida, K. Ono, T. Shioi, M. Okada, A. Iwasaki, R. Nishio, K. Matsushima, and S. Sasayama Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction J. Mol. Cell. Cardiol. 29 1997 419 423
113. M.I. Mäyränpää, H.M. Heikkilä, K.A. Lindstedt, A.F. Walls, and P.T. Kovanen Desquamation of human coronary artery endothelium by human mast cell proteases: implications for plaque erosion Coron. Artery Dis. 17 2006 611 621
114. M.I. Mäyränpää, J.A. Trosien, V. Fontaine, M. Folkesson, M. Kazi, P. Eriksson, J. Swedenborg, and U. Hedin Mast cells associate with neovessels in the media and adventitia of abdominal aortic aneurysms J. Vasc. Surg. 50 2009 388 395
115. Z. Meng, C. Yan, Q. Deng, X. Dong, Z.M. Duan, D.F. Gao, and X.L. Niu Oxidized low-density lipoprotein induces inflammatory responses in cultured human mast cells via Toll-like receptor 4 Cell. Physiol. Biochem. 31 2013 842 853
116. K.P. Metsärinne, P. Vehmaan-Kreula, P.T. Kovanen, O. Saijonmaa, M. Baumann, Y. Wang, T. Nyman, F.Y. Fyhrquist, and K.K. Eklund Activated mast cells increase the level of Endothelin-1 mRNA in cocultured endothelial cells and degrade the secreted peptide Arterioscler. Thromb. Vasc. Biol. 22 2002 268 273
117. M. Miyazaki, N. Shiota, H. Sakonjo, and S. Takai Angiotensin II type 1 receptor antagonist, TCV-116, prevents neointima formation in injured arteries in the dog Jpn. J. Pharmacol. 79 1999 455 460
118. N. Miyazawa, S. Watanabe, A. Matsuda, K. Kondo, H. Hashimoto, K. Umemura, and M. Nakashima Role of histamine H1 and H2 receptor antagonists in the prevention of intimal thickening Eur. J. Pharmacol. 362 1998 53 59
119. M. Moreno, J. Puig, M. Serrano, J.M. Moreno-Navarrete, F. Ortega, W. Ricart, and J.M. Fernandez-Real Circulating tryptase as a marker for subclinical atherosclerosis in obese subjects PLoS One 9 2014 e97014
120. C. Morrey, J. Brazin, N. Seyedi, F. Corti, R.B. Silver, and R. Levi Interaction between sensory C-fibers and cardiac mast cells in ischemia/reperfusion: activation of a local renin-angiotensin system culminating in severe arrhythmic dysfunction J. Pharmacol. Exp. Ther. 335 2010 76 84
121. D.B. Murray, J.D. Gardner, G.L. Brower, and J.S. Janicki Endothelin-1 mediates cardiac mast cell degranulation, matrix metalloproteinase activation, and myocardial remodeling in rats Am. J. Physiol. Heart Circ. Physiol. 287 2004 H2295 H2299
122. Y.N. Nabah, T. Mateo, R. Estellés, M. Mata, J. Zagorski, H. Sarau, J. Cortijo, E.J. Morcillo, P.J. Jose, and M.J. Sanz Angiotensin II induces neutrophil accumulation in vivo through generation and release of CXC chemokines Circulation 110 2004 3581 3586
123. S. Nistri, L. Cinci, A.M. Perna, E. Masini, R. Mastroianni, and D. Bani Relaxin induces mast cell inhibition and reduces ventricular arrhythmias in a swine model of acute myocardial infarction Pharmacol. Res. 57 2008 43 48
124. B. Oh, and C.H. Lee Nanofiber-coated drug eluting stent for the stabilization of mast cells Pharm. Res. 31 2014 2463 2478
125. R. Oksjoki, P. Laine, S. Helske, P. Vehmaan-Kreula, M.I. Mäyränpää, P. Gasque, P.T. Kovanen, and M.O. Pentikäinen Receptors for the anaphylatoxins C3a and C5a are expressed in human atherosclerotic coronary plaques Atherosclerosis 195 2007 90 99
126. K. Okumura, S. Takai, M. Muramatsu, S. Katayama, M. Sakaguchi, K. Kishi, D. Jin, and M. Miyazaki Human chymase degrades human fibronectin Clin. Chim. Acta 347 2004 223 225
127. S.A. Oldford, and J.S. Marshall Mast cells as targets for immunotherapy of solid tumors Mol. Immunol. 63 2015 113 124
128. S.H. Oliveira, and N.W. Lukacs Stem cell factor and igE-stimulated murine mast cells produce chemokines (CCL2, CCL17, CCL22) and express chemokine receptors Inflamm. Res. 50 2001 168 714
129. E. Ollikainen, R. Tulamo, J. Frösen, S. Lehti, P. Honkanen, J. Hernesniemi, M. Niemelä, and P.T. Kovanen Mast cells, neovascularization, and microhemorrhages are associated with saccular intracranial artery aneurysm wall remodeling J. Neuropathol. Exp. Neurol. 73 2014 855 864
130. S. Oyamada, C. Bianchi, S. Takai, L.M. Chu, and F.W. Sellke Chymase inhibition reduces infarction and matrix metalloproteinase-9 activation and attenuates inflammation and fibrosis after acute myocardial ischemia/reperfusion J. Pharmacol. Exp. Ther. 339 2011 143 151
131. L. Pang, M. Nie, L. Corbett, A. Sutcliffe, and A.J. Knox Mast cell beta-tryptase selectively cleaves eotaxin and RANTES and abrogates their eosinophil chemotactic activities J. Immunol. 176 2006 3788 3795
132. G. Pejler, E. Rönnberg, I. Waern, and S. Wernersson Mast cell proteases: multifaceted regulators of inflammatory disease Blood 115 2010 4981 4990
133. M.O. Pentikäinen, K. Oörni, M. Ala-Korpela, and P.T. Kovanen Modified LDL - trigger of atherosclerosis and inflammation in the arterial intima J. Intern. Med. 247 2000 359 370
134. P. Prasad, A.K. Tiwari, K.M. Kumar, A.C. Ammini, A. Gupta, R. Gupta, A.K. Sharma, A.R. Rao, R. Nagendra, T.S. Chandra, S.C. Tiwari, P. Rastogi, B.L. Gupta, and B.K. Thelma Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms BMC Med. Genet. 7 2006 42
135. D.J. Rader, and E. Puré Lipoproteins, macrophage function, and atherosclerosis: beyond the foam cell? Cell Metab. 1 2005 223 230
136. K. Rakusan, K. Sarkar, Z. Turek, and P. Wicker Mast cells in the rat heart during normal growth and in cardiac hypertrophy Circ. Res. 66 1990 511 516
137. L.S. Ramalho, L.F. Oliveira, C.L. Cavellani, M.L. Ferraz, F.A. de Oliveira, R.R. Miranda Corrêa, V. de Paula Antunes Teixeira, and S.A. De Lima Pereira Role of mast cell chymase and tryptase in the progression of atherosclerosis: study in 44 autopsied cases Ann. Diagn. Pathol. 17 2013 28 31
138. J.J. Reimerink, M.J. van der Laan, M.J. Koelemay, R. Balm, and D.A. Legemate Systematic review and meta-analysis of population-based mortality from ruptured abdominal aortic aneurysm Br. J. Surg. 100 2013 1405 1413
139. R. Rodrigues-Diez, C. Lavoz, G. Carvajal, S. Rayego-Mateos, R.R. Rodrigues Diez, A. Ortiz, J. Egido, S. Mezzano, and M. Ruiz-Ortega Gremlin is a downstream profibrotic mediator of transforming growth factor-beta in cultured renal cells Nephron Exp. Nephrol. 122 2012 62 74
140. B.M. Rüger, Q. Hasan, N.S. Greenhill, P.F. Davis, P.R. Dunbar, and T.J. Neale Mast cells and type VIII collagen in human diabetic nephropathy Diabetologia 39 1996 1215 1222
141. J. Saarinen, N. Kalkkinen, H.G. Welgus, and P.T. Kovanen Activation of human interstitial procollagenase through direct cleavage of the Led3-ThrS4 J. Biol. Chem. 269 1994 18134 18140
142. S. Sasaki, and T. Inoguchi The role of oxidative stress in the pathogenesis of diabetic vascular complications Diabetes Metab. J. 36 2012 255 261
143. N. Shiota, H. Okunishi, S. Takai, I. Mikoshiba, H. Sakonjo, N. Shibata, and M. Miyazaki Tranilast suppresses vascular chymase expression and neointima formation in balloon-injured dog carotid artery Circulation 99 1999 1084 1090
144. Y. Sasaguri, and A. Tanimoto Role of macrophage-derived histamine in atherosclerosis - chronic participation in the inflammatory response J. Atheroscler. Thromb. 11 2004 122 130
145. N. Seyedi, C.J. Mackins, T. Machida, A.C. Reid, R.B. Silver, and R. Levi Histamine H3-receptor-induced attenuation of norepinephrine exocytosis: a decreased protein kinase a activity mediates a reduction in intracellular calcium J. Pharmacol. Exp. Ther. 312 2005 272 280
146. I. Shefler, P. Salamon, A.Y. Hershko, and Y.A. Mekori Mast cells as sources and targets of membrane vesicles Curr. Pharm. Des. 17 2011 3797 3804
147. R. Sibilano, B. Frossi, and C.E. Pucillo Mast cell activation: a complex interplay of positive and negative signaling pathways Eur. J. Immunol. 44 2014 2558 2566
148. R.B. Silver, A.C. Reid, C.J. Mackins, T. Askwith, U. Schaefer, D. Herzlinger, and R. Levi Mast cells: a unique source of renin Proc. Natl. Acad. Sci. USA 101 2004 13607 13612
149. N. Sismanopoulos, D.A. Delivanis, D. Mavrommati, E. Hatziagelaki, P. Conti, and T.C. Theoharides Do mast cells link obesity and asthma? Allergy 68 2013 8 15
150. D. Skokos, H. Goubran-Botros, M. Roa, and S. Mécheri Immunoregulatory properties of mast cell-derived exosomes Mol. Immunol. 38 2002 1359 1362
151. N. Skovgaard, K. Møller, H. Gesser, and T. Wang Histamine induces postprandial tachycardia through a direct effect on cardiac H2-receptors in pythons Am. J. Physiol. Regul. Integr. Comp. Physiol. 296 2009 R774 R785
152. D.D. Smith, X. Tan, V.V. Raveendran, O. Tawfik, D.J. Stechschulte, and K.N. Dileepan Mast cell deficiency attenuates progression of atherosclerosis and hepatic steatosis in apolipoprotein E-null mice Am. J. Physiol. Heart Circ. Physiol. 302 2012 H2612 H2621
153. P. Somasundaram, G. Ren, H. Nagar, D. Kraemer, L. Mendoza, L.H. Michael, G.H. Caughey, M.L. Entman, and N.G. Frangogiannis Mast cell tryptase may modulate endothelial cell phenotype in healing myocardial infarcts J. Pathol. 205 2005 102 111
154. W.G. Stevenson Ventricular tachycardia after myocardial infarction: from arrhythmia surgery to catheter ablation J. Cardiovasc. Electrophysiol. 6 1995 942 950
155. J. Sun, G.K. Sukhova, P.J. Wolters, M. Yang, S. Kitamoto, P. Libby, L.A. MacFarlane, J. Mallen-St Clair, and G.P. Shi Mast cells promote atherosclerosis by releasing proinflammatory cytokines Nat. Med. 13 2007 719 724
156. J. Sun, G.K. Sukhova, M. Yang, P.J. Wolters, L.A. MacFarlane, P. Libby, C. Sun, Y. Zhang, J. Liu, T.L. Ennis, R. Knispel, W. Xiong, R.W. Thompson, B.T. Baxter, and G.P. Shi Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice J. Clin. Investig. 117 2007 3359 3368
157. J. Sun, J. Zhang, J.S. Lindholt, G.K. Sukhova, J. Liu, A. He, M. Abrink, G. Pejler, R.L. Stevens, R.W. Thompson, T.L. Ennis, M.F. Gurish, P. Libby, and G.P. Shi Critical role of mast cell chymase in mouse abdominal aortic aneurysm formation Circulation 120 2009 973 982
158. J. Swedenborg, M.I. Mäyränpää, and P.T. Kovanen Mast cells: important players in the orchestrated pathogenesis of abdominal aortic aneurysms Arterioscler. Thromb. Vasc. Biol. 31 2011 734 740
159. E.J. Swindle, and D.D. Metcalfe The role of reactive oxygen species and nitric oxide in mast cell-dependent inflammatory processes Immunol. Rev. 217 2007 186 205
160. L. Szalay, J. Kaszaki, S. Nagy, and M. Boros Endothelin-1 induces mucosal mast cell degranulation in the rat small intestine Life Sci. 67 2000 1947 1958
161. J. Taipale, J. Lohi, J. Saarinen, P.T. Kovanen, and J. Keski-Oja Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial and endothelial cells J. Biol. Chem. 270 1995 4689 4696
162. A. Tanaka, Y. Nomura, A. Matsuda, K. Ohmori, and H. Matsuda Mast cells function as an alternative modulator of adipogenesis through 15-deoxy-delta-12, 14-prostaglandin J2 Am. J. Physiol. Cell. Physiol. 301 2011 1360 1367
163. E. Tchougounova, A. Lundequist, I. Fajardo, J.O. Winberg, M. Abrink, and G. Pejler A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2 J. Biol. Chem. 280 2005 9291 9296
164. G.M. Tennant, R.M. Wadsworth, and S. Kennedy PAR-2 mediates increased inflammatory cell adhesion and neointima formation following vascular injury in the mouse Atherosclerosis 198 2008 57 64
165. S. Tsimikas, and Y.I. Miller Oxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications in cardiovascular disease Curr. Pharm. Des. 17 2011 27 37
166. K. Tsunemi, S. Takai, M. Nishimoto, D. Jin, M. Sakaguchi, M. Muramatsu, A. Yuda, S. Sasaki, and M. Miyazaki A specific chymase inhibitor, 2-(5-formylamino-6-oxo-2-phenyl-1,6-dihydropyrimidine-1-yl)-N-[[3,4-dioxo-1-phenyl-7-(2-pyridyloxy)]-2-heptyl]acetamide (NK3201), suppresses development of abdominal aortic aneurysm in hamsters J. Pharmacol. Exp. Ther. 309 2004 879 883
167. T. Tsuruda, J. Kato, K. Hatakeyama, A. Yamashita, K. Nakamura, T. Imamura, K. Kitamura, T. Onitsuka, Y. Asada, and T. Eto Adrenomedullin in mast cells of abdominal aortic aneurysm Cardiovasc. Res. 70 2006 158 164
168. T. Tsuruda, J. Kato, K. Hatakeyama, K. Kojima, M. Yano, Y. Yano, K. Nakamura, F. Nakamura-Uchiyama, Y. Matsushima, T. Imamura, T. Onitsuka, Y. Asada, Y. Nawa, T. Eto, and K. Kitamura Adventitial mast cells contribute to pathogenesis in the progression of abdominal aortic aneurysm Circ. Res. 102 2008 1368 1377
169. H. Urata Pathological involvement of chymase-dependent angiotensin II formation in the development of cardiovascular disease J. Renin Angiotensin Aldosterone Syst. 1 2000 S35 S37
170. S. Varadaradjalou, F. Féger, N. Thieblemont, N.B. Hamouda, J.M. Pleau, M. Dy, and M. Arock Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells Eur. J. Immunol. 33 2003 899 906
171. R.B. Vukmir Cardiac arrhythmia diagnosis Am. J. Emerg. Med. 13 1995 204 210
172. F. Waanders, F.W. Visser, and R.O. Gans Current concepts in the management of diabetic nephropathy Neth. J. Med. 71 2013 448 458
173. Y. Wang, N. Shiota, M.J. Leskinen, K.A. Lindstedt, and P.T. Kovanen Mast cell chymase inhibits smooth muscle cell growth and collagen expression in vitro: transforming growth factor-beta1-dependent and -independent effects Arterioscler. Thromb. Vasc. Biol. 21 2001 1928 1933
174. J. Wang, S. Sjöberg, V. Tia, B. Secco, H. Chen, M. Yang, G.K. Sukhova, and G.P. Shi Pharmaceutical stabilization of mast cells attenuates experimental atherogenesis in low-density lipoprotein receptor-deficient mice Atherosclerosis 229 2009 304 309
175. J. Wang, X. Cheng, M.X. Xiang, M. Alanne-Kinnunen, J.A. Wang, H. Chen, A. He, X. Sun, Y. Lin, T.T. Tang, X. Tu, S. Sjöberg, G.K. Sukhova, Y.H. Liao, D.H. Conrad, L. Yu, T. Kawakami, P.T. Kovanen, P. Libby, and G.P. Shi IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe-/- mice J. Clin. Investig. 121 2011 3564 3577
176. J. Wang, J.S. Lindholt, G.K. Sukhova, M.A. Shi, M. Xia, H. Chen, M. Xiang, A. He, Y. Wang, N. Xiong, P. Libby, J.A. Wang, and G.P. Shi IgE actions on CD4+ T cells, mast cells, and macrophages participate in the pathogenesis of experimental abdominal aortic aneurysms EMBO Mol. Med. 6 2014 952 969
177. H. Wasse, N. Naqvi, and A. Husain Impact of mast cell chymase on renal disease progression Curr. Hypertens. Rev. 8 2012 15 23
178. C.C. Wei, N. Hase, Y. Inoue, E.W. Bradley, E. Yahiro, M. Li, N. Naqvi, P.C. Powell, K. Shi, Y. Takahashi, K. Saku, H. Urata, L.J. Dell'italia, and A. Husain Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodents J. Clin. Investig. 120 2010 1229 1239
179. W.S. Weintraub The pathophysiology and burden of restenosis Am. J. Cardiol. 100 2007 3K 9K
180. S.P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, and A.W. Ferrante Jr. Obesity is associated with macrophage accumulation in adipose tissue J. Clin. Investig. 112 2003 1796 1808
181. S. Wernersson, and G. Pejler Mast cell secretory granules: armed for battle Nat. Rev. Immunol. 14 2014 478 494
182. R. Wessely New drug-eluting stent concepts Nat. Rev. Cardiol. 7 2010 194 203
183. S. Willems, A. Vink, I. Bot, P.H. Quax, G.J. de Borst, J.P. de Vries, S.M. van de Weg, F.L. Moll, J. Kuiper, P.T. Kovanen, D.P. de Kleijn, I.E. Hoefer, and G. Pasterkamp Mast cells in human carotid atherosclerotic plaques are associated with intraplaque microvessel density and the occurrence of future cardiovascular events Eur. Heart J. 34 2013 3699 3706
184. A.A. Wolff, and R. Levi Histamine and cardiac arrhythmias Circ. Res. 58 1986 1 16
185. A.A. Wolff, and R. Levi Ventricular arrhythmias parallel cardiac histamine efflux after coronary artery occlusion in the dog Agents Actions 25 1988 296 306
186. M.R. Woolhiser, Y. Okayama, A.M. Gilfillan, and D.D. Metcalfe IgG-dependent activation of human mast cells following up-regulation of FcgammaRI by IFN-gamma Eur. J. Immunol. 31 2001 3298 3307
187. J.M. Xu, and G.P. Shi Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases Endocr. Rev. 33 2012 71 108
188. P. Yeong, Y. Ning, Y. Xu, X. Li, and L. Yin Tryptase promotes human monocyte-derived macrophage foam cell formation by suppressing LXRalpha activation Biochim. Biophys. Acta 1801 2010 567 576
189. L. Yu, W.A. Border, Y. Huang, and N.A. Noble TGF-beta isoforms in renal fibrogenesis Kidney Int. 64 2003 844 856
190. A. Zernecke, E. Shagdarsuren, and C. Weber Chemokines in atherosclerosis: an update Arterioscler. Thromb. Vasc. Biol. 28 2008 1897 1908
191. J. Zhang, P. Alcaide, L. Liu, J. Sun, A. He, F.W. Luscinskas, and G.P. Shi Regulation of endothelial cell adhesion molecule expression by mast cells, macrophages, and neutrophils PLoS One 6 2011 e14525
192. J. Zhang, H. Chen, L. Liu, J. Sun, M.A. Shi, G.K. Sukhova, and G.P. Shi Chemokine (C-C motif) receptor 2 mediates mast cell migration to abdominal aortic aneurysm lesions in mice Cardiovasc. Res. 96 2012 543 551
193. J. Zhang, J. Sun, J.S. Lindholt, G.K. Sukhova, M. Sinnamon, R.L. Stevens, R. Adachi, P. Libby, R.W. Thompson, and G.P. Shi Mast cell tryptase deficiency attenuates mouse abdominal aortic aneurysm formation Circ. Res. 108 2012 1316 1327
194. W. Zhao, C.A. Oskeritzian, A.L. Pozez, and L.B. Schwartz Cytokine production by skin-derived mast cells: endogenous proteases are responsible for degradation of cytokines J. Immunol. 175 2005 2635 2642
195. X. Zhi, C. Xu, H. Zhang, D. Tian, X. Li, Y. Ning, and L. Yin Tryptase promotes atherosclerotic plaque haemorrhage in ApoE-/- mice PLoS One 8 2013 e60960